Leap Therapeutics uses 8 technology products and services including Microsoft Excel, RequireJS, Prototype, and more. Explore Leap Therapeutics's tech stack below.
| Leap Therapeutics Email Formats | Percentage |
| FLast@leaptx.com | 49% |
| Last@leaptx.com | 2% |
| FLast@leaptx.com | 49% |
Biotechnology ResearchMassachusetts, United States11-50 Employees
Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. For more information about Leap Therapeutics, visit http://www.leaptx.com or our public filings with the SEC that are available via EDGAR at http://www.sec.gov or via http://www.investors.leaptx.com.
Company Overview
Media & News
Funding & FinancialsLeap Therapeutics has raised a total of $40M of funding over 10 rounds. Their latest funding round was raised on Apr 10, 2024 in the amount of $40M.
Leap Therapeutics's revenue is in the range of $10M
Funding & FinancialsLeap Therapeutics has raised a total of $40M of funding over 10 rounds. Their latest funding round was raised on Apr 10, 2024 in the amount of $40M.
Leap Therapeutics's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com